We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Charnwood Molecular

News List

CRO Charnwood Molecular Expands Capabilities contractpharma
July 19, 2021
$75m construction project in Loughborough creates flexible facility for the growing CRO.
UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021 pharmatimes
April 30, 2021
UK-based contract research organisation (CRO) Charnwood Molecular has revealed its plans for expansion in 2021, which includes becoming the sole occupier of a ‘substantial’ laboratory facility in Loughborough.
Charnwood Molecular Plans Significant Expansion contractpharma
April 29, 2021
Charnwood Molecular, a UK-based preclinical discovery CRO servicing the global pharmaceutical and biopharma market, is planning a significant expansion in 2021.
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics europeanpharmaceuticalreview
May 20, 2020
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.